Correction: Modelled mortality benefits of multi-cancer early detection screening in England
Br J Cancer
.
2024 Dec;131(12):1942-1944.
doi: 10.1038/s41416-024-02836-y.
Authors
Peter Sasieni
1
,
Rebecca Smittenaar
2
,
Earl Hubbell
3
,
John Broggio
4
,
Richard D Neal
5
,
Charles Swanton
6
7
Affiliations
1
Comprehensive Cancer Centre, King's College London, Guy's Campus, Great Maze Pond, London, SE1 1UL, UK.
[email protected]
.
2
GRAIL Bio UK Ltd, a subsidiary of GRAIL, LLC, London, WC1V 7HP, UK.
3
GRAIL, LLC, Menlo Park, CA, 94025, USA.
4
NHS Digital, 7 and 8 Wellington Place, Leeds, West Yorkshire, LS1 4AP, UK.
5
Department of Health and Community Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
6
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, WC1E 6DD, UK.
7
Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, NW1 1AT, UK.
PMID:
39558064
PMCID:
PMC11628565
DOI:
10.1038/s41416-024-02836-y
No abstract available
Publication types
Published Erratum